Skip to main content
I

IPMD

IPMD provides AI‑driven emotional insight solutions for businesses and healthcare providers, delivering accurate facial and emotional analysis through its suite of platforms. Its offerings include an Emotional AI mobile app for on‑the‑go sentiment detection, a telemedicine platform that enhances patient‑provider interactions, and the EchoBloom Initiatives, which combine emotional AI with artists and individuals with disabilities to create therapeutic art. These tools aim to improve talent acquisition, clinical decision‑making, and inclusive creative expression.

Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Businesses and healthcare providers often lack objective, real-time insight into patients' or users' emotional states, relying on self‑reporting or limited observational cues that can miss subtle or hard‑to‑detect facial expressions. This gap reduces the effectiveness of talent acquisition assessments, telemedicine consultations, and therapeutic interventions.

Solution

IPMD offers AI‑driven emotional insight platforms that analyze facial cues to deliver quantitative emotion data at scale. Their mobile app provides on‑the‑go emotional analysis, while the telemedicine platform integrates real‑time emotion detection into virtual clinical encounters, helping clinicians identify hidden distress or pain. The EchoBloom initiative combines emotional AI with artists and individuals with disabilities to create therapeutic art, extending the technology’s impact beyond analytics. Across all products, IPMD’s models achieve high accuracy (95% ROC/AUC) and deliver actionable emotional context to support decision‑making in hiring, patient care, and creative therapy.

Target Audience

Primary customers include enterprises conducting talent acquisition, telemedicine providers and clinicians seeking enhanced patient monitoring, and organizations running therapeutic art programs for individuals with disabilities.

Features

  • Real‑time facial emotion detection using proprietary AI models with 95% ROC/AUC accuracy
  • Mobile application that captures and analyzes emotional cues instantly for on‑the‑go insights
  • Telemedicine integration that overlays emotion analytics onto video consultations to aid clinical assessment
  • RESTful API for secure, scalable access to emotion data, built on Google Cloud and NVIDIA GPU acceleration
  • EchoBloom creative program that merges AI‑generated emotional insights with collaborative art for therapeutic purposes
  • Data encryption and privacy controls compliant with healthcare standards for secure transmission and storage
This profile is AI-generated and may contain inaccuracies.